Corey N. Fishman is Chief Executive Officer of Iterum Therapeutics plc. Currently has a direct ownership of 137,062 shares of ITRM, which is worth approximately $178,180. The most recent transaction as insider was on Aug 06, 2024, when has been sold 82,613 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 137K
151.73% 3M change
208.36% 12M change
Total Value Held $178,180

Corey N. Fishman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 06 2024
BUY
Exercise of conversion of derivative security
-
82,613 Added 37.61%
137,062 Ordinary Shares
Nov 20 2023
BUY
Open market or private purchase
$15,900 $1.59 p/Share
10,000 Added 15.52%
54,449 Ordinary Shares
Mar 11 2023
SELL
Payment of exercise price or tax liability
$5,455 $0.96 p/Share
5,683 Reduced 11.34%
44,449 Ordinary Shares
Mar 11 2023
BUY
Grant, award, or other acquisition
-
14,333 Added 22.23%
50,132 Ordinary Shares
Mar 11 2022
BUY
Exercise of conversion of derivative security
-
215,000 Added 28.59%
537,008 Ordinary Shares
Jan 26 2021
SELL
Open market or private sale
$147,820 $1.73 p/Share
85,445 Reduced 20.97%
322,008 Ordinary Shares
Jan 25 2021
BUY
Grant, award, or other acquisition
-
167,500 Added 29.13%
407,453 Ordinary Shares
CNF

Corey N. Fishman

Chief Executive Officer
Dublin, L2

Track Institutional and Insider Activities on ITRM

Follow Iterum Therapeutics plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ITRM shares.

Notify only if

Insider Trading

Get notified when an Iterum Therapeutics PLC insider buys or sells ITRM shares.

Notify only if

News

Receive news related to Iterum Therapeutics plc

Track Activities on ITRM